We can also decrease your dosage so your body can adjust to the medication
Research presented at the European Congress on Obesity in 2024, for instance, found that people who gradually reduced their dose to zero (over an average of nine weeks) maintained a stable body weight in the first 26 weeks after tapering
Using the FDA Adverse Event Reporting System (FAERS) from 2017 through late 2023, researchers identified more than 181,000 adverseevent reports involving dupilumab, including 606 describing neoplasms
Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer
For further information, see the NICE guideline on obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s, and British Thoracic Society guidance on obesity-related respiratory impairment